Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares are up nearly 9% in early trading Tuesday after the embattled pharmaceutical company reported that it will sell assets …
Illumina, Inc.(NASDAQ:ILMN) announced a strategic collaboration, that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ …
Illumina, Inc. (NASDAQ:ILMN) announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed …
Illumina, Inc. (NASDAQ:ILMN) announced it has named one of the world’s top clinical genomics experts to head its clinical genomics unit.
Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team …
Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Sam A.
Illumina, Inc. (NASDAQ:ILMN) announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm …
Gilead Sciences, Inc. Yesterday, Gilead Sciences, Inc.
Illumina, Inc. (NASDAQ:ILMN) announced its full financial results for the third quarter of fiscal year 2016.
Illumina, Inc. Illumina, Inc.
